Colossal Biosciences, the world’s first company dedicated to bringing back animals from extinction, has secured $200 million in series C funding. The latest investment announced Wednesday doubles the tech company’s total funding to $435 million since its 2021 launch, boosting the company’s valuation to $10.2 billion.